Cargando…
Influence of Late Vascular Inflammation on Long‐Term Outcomes Among Patients Undergoing Implantation of Drug Eluting Stents: Role of C‐Reactive Protein
BACKGROUND: Elevation of C‐reactive protein (CRP) as a marker of vascular inflammation at a late phase of drug‐eluting stent (DES) implantation may predict subsequent major adverse cardiac events (MACE). METHODS AND RESULTS: In 1234 consecutive patients undergoing DES implantation, CRP was measured...
Autores principales: | Shiba, Masanori, Itaya, Hideki, Iijima, Raisuke, Nakamura, Masato |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5079011/ https://www.ncbi.nlm.nih.gov/pubmed/27664802 http://dx.doi.org/10.1161/JAHA.116.003354 |
Ejemplares similares
-
Extensive Late-Acquired Incomplete Stent Apposition After Sirolimus-Eluting Stent Implantation
por: Choi, Hyun-Chul, et al.
Publicado: (2010) -
Coronary Aneurysm Occurring Late after Drug-Eluting Stent Implantation
por: Abergel, Etan, et al.
Publicado: (2011) -
Very Late Stent Thrombosis due to Neointimal Rupture After Paclitaxel-Eluting Stent Implantation
por: Kee, Won Ju, et al.
Publicado: (2011) -
Impact of Coronary Plaque Characteristics on Late Stent Malapposition after Drug-Eluting Stent Implantation
por: Hong, Sung-Jin, et al.
Publicado: (2015) -
Extremely Late In-Stent Thrombosis 12 Years After Implantation of a Drug-Eluting Stent
por: Sleiman, Elsa, et al.
Publicado: (2020)